| Nurse Practitioner Home | Course Catalog | My Stuff | Privacy | About | Login
You are here:  Home   Program   Course AB0496
FAQ Case in Review: Practice Pearls for Managing COPD  Accreditation
Feedback Supporter Information
  Bibliography
 

(Course AB0496)

Written By Margaret Lester, RN, MSN, FNP, AE-C

In this interactive and informative Case in Review, Margaret Lester, RN, MSN, FNP, AE-C will present a patient scenario based on her real-life experiences in managing chronic obstructive pulmonary disease (COPD) as part of office-based care. Step by step from initial presentation to follow-up, she guides you through the critical steps of assessing the patient’s risk factors, making the diagnosis, planning and administering treatment, and providing ongoing care. As she present details of the case, you can test your knowledge in each of these areas. For help, you can visit the medical library to review current clinical-practice guidelines and other resources. The course gives you the opportunity to hone your skills and then apply them in your daily practice.

You will need:

Overview

This comprehensive program is designed to help you recognize the challenges of diagnosing, preventing, and treating COPD and to apply current evidence-based guidelines in selecting appropriate screening, testing, education, and treatment options to improve the care of your patients with COPD.

 
Learning Objectives
Upon completion of this course, you should be able to:

  • Classify severity in newly diagnosed COPD and identify treatment strategies for stable COPD

  • Differentiate between symptoms of asthma and COPD

  • Adjust treatment for COPD based on comorbid conditions

Target Audience
The CE activity is designed for nurse practitioners and other healthcare providers who manage patients with chronic obstructive pulmonary disease.

Learner Participation to Earn Credit

Faculty Disclosures
Margaret Lester, RN, MSN, FNP, AE-C  [BioSketch]
Assistant Chief Executive and Director of Educational Programs, National Respiratory Training Center, South Pasadena, CA
Disclosure: Consultant/Speaker: GlaxoSmithKline, Altana/Pfizer; Speaker: Boehringer Ingelheim
Conflict of Interest/Disclosure Statement

As a provider of CME and CE activities that are accredited by AANP, AAPA and AARC, MEBN must ensure balance, independence, objectivity and scientific rigor in all of its CME activities. All faculty participating in these activities are expected to disclose any or no relevant financial interest or other relationship with (1) the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in any educational presentation, and/or (2) with any commercial supporters of an activity. Disclosure of any or no relationship(s) will be listed prior to any educational activity. All apparent conflicts of interest have been identified and resolved through MEBN’s independent, peer-review process. Our intent is to assist learners in assessing the potential for bias in information that is presented during the CME activity. The faculty are also aware of their responsibility to inform the audience if discussion of any non-FDA-approved uses of pharmaceuticals, medical equipment, prostheses, etc. will be included in their presentation.

Accreditation Statement
 

Continuing Medical Education for Nurse Practitioners  

This program has been approved for 1 contact hour(s) of continuing education (which includes .5 hours of pharmacology) by the American Academy of Nurse Practitioners, Program ID 0603095. This program is eligible for contact hours through May 31, 2008.

 

Disclaimer
This continuing education program may contain discussion of published and/or investigational uses of agents or products that are not approved by the Food and Drug Administration (FDA). The authors, sponsors or publishers do not recommend the use of any agent or product outside of the official labeled indications. Please refer to the official prescribing information for each agent or product for discussion of approved indications, contraindications, and written warnings.

Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this course should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The authors, contributors, and editorial staff have made every effort to contact holders of copyright to obtain permission to reproduce copyright material. However, if any permissions have been inadvertently overlooked, MEBN will be pleased to make the necessary and reasonable arrangements.

Supported by an educational grant from
 

Produced in partnership with the
 

www.boehringer-ingelheim.com www.pfizer.com www.aanp.org

Certificate Fees

CE-TODAY offers FREE continuing education (CE) credits to recipients of the CD-ROM or the CE-TODAY journal. Enter the CE Code listed on the CD-ROM or in the journal when prompted. This free offer expires on May 26, 2007. All others will be assessed a $10.00 processing fee.